Skip to content

Treatment of residual band movement after facial paralysis based on tendon theory--prospective multicenter randomized controlled study

Treatment of residual band movement after facial paralysis based on tendon theory--prospective multicenter randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005517
Enrollment
Unknown
Registered
2022-01-09
Start date
2021-12-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Synkinesis

Interventions

Sponsors

Affiliated Hospital of Chengdu University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria of facial paralysis, and the onset of facial paralysis in more than 3 months and facial paralysis side of the patients with synapse movement. ? Patients with facial synband movement were assessed as mild or above by Sunnybrook(Toronto) facial nerve assessment system. ? Between 18 and 80 years old. ? Normal mind, can correctly express independent opinion, can cooperate with treatment. ? Those who volunteered to participate in the study and signed the informed consent.

Exclusion criteria

Exclusion criteria: ? Patients with facial nerve injury due to jaw and neck injury, brain injury, tumor surgery and other non-Bell's palsy and Hunt syndrome. ? Only primary and secondary hemifacial spasm. ? Patients with primary and secondary trigeminal nerve pain. ? Conscious disorder and unstable condition. ? Serious primary diseases associated with cardiovascular, liver, kidney, lung and hematopoietic system have not been effectively controlled. ? Pregnancy and puerperium. ? There are needle sickness, facial skin allergy and infection. ? People who have recently taken central muscle relaxation drugs, neurobotulinum toxin, alcohol and other nerve or motor point block treatment. ? is receiving other clinical investigators.

Design outcomes

Primary

MeasureTime frame
Sunnybrook Facial Grading System;

Secondary

MeasureTime frame
Facial disability index;Facial asymmetry;House–Brackmann Facial Nerve Grading System;Self-rating depression scale;SelfRating Anxiety Scale;

Countries

China

Contacts

Public ContactLi Dehua

Affiliated Hospital of Chengdu University of TCM

si_ff@163.com18980079361

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026